← Back to Search

Other

Positioning Technique for Hip Surgery

N/A
Recruiting
Led By Vehniah K Tjong, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients presenting to Northwestern Memorial Hospital (NMH) or to a Northwestern orthopaedic surgery faculty member's clinic undergoing hip arthroscopy
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours after surgery
Awards & highlights

Study Summary

This trial is testing whether using a traction pad during hip arthroscopy can reduce the incidence and duration of postoperative perineal numbness.

Who is the study for?
This trial is for English-speaking patients at Northwestern Memorial Hospital or its orthopaedic clinics who are undergoing hip arthroscopy for conditions like osteoarthritis or hip strain. It's not open to those who've had previous surgeries, cancer-related surgery, or will receive regional anesthesia.Check my eligibility
What is being tested?
The study tests the Pink Pad Hip Kit during hip arthroscopic surgery to see if it reduces postoperative numbness. The kit is used with a standard traction table and perineal post to lessen pressure on the groin area during surgery.See study design
What are the potential side effects?
While the trial aims to reduce side effects, potential risks may include discomfort from using the Pink Pad Hip Kit or residual numbness in the perineal region despite its use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am getting hip arthroscopy at Northwestern Memorial Hospital or by a Northwestern orthopaedic surgeon.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
patient-reported numbness
patient-reported post-operative numbness
Secondary outcome measures
patient-reported difficulty urinating
patient-reported difficulty with bowel movements
patient-reported sexual disfunction or erectile disfunction
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pink PadExperimental Treatment1 Intervention
Hip arthroscopy using The Pink Pad Hip Kit Patient Positioning System (Xodus Medical, New Kensington, PA). The pad is placed between the patient and the traction table, using a perineal post.
Group II: Control (No pad)Active Control1 Intervention
Hip arthroscopy in the usual fashion, no pad, using traction table with perineal post.

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,586 Previous Clinical Trials
916,899 Total Patients Enrolled
Vehniah K Tjong, MDPrincipal InvestigatorNorthwestern University
2 Previous Clinical Trials
30 Total Patients Enrolled

Media Library

Positioning for Hip Arthroscopic Surgery (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05038709 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be a good candidate to join this clinical trial based on the eligibility requirements?

"Up to 120 patients with hip injuries will be accepted into this study. The ideal candidate is aged 18-88 and must have received a hip arthroscopy from Northwestern Memorial Hospital or a faculty member's clinic."

Answered by AI

What are the main goals that we hope to accomplish with this research?

"The primary focus of this study will be on post-operative numbness as reported by the patient. This will be evaluated over a period of 6 weeks post-surgery. Additionally, secondary objectives include patient-reported skin changes or breakdown, sexual dysfunction or erectile dysfunction, and difficulty urinating."

Answered by AI

Is this test only available to people 45 and older?

"The lower age limit for this study is 18 years old and the upper age limit is 88 years old."

Answered by AI

How many patients are giving permission to participate in this trial?

"That is correct, the online clinicaltrials.gov registry currently lists this study as open and recruiting. The listing dates back to October 12th, 2021 and was last updated on December 7th, 2021. They are looking for a total of 120 individuals across 1 site."

Answered by AI
~34 spots leftby Apr 2025